Gene therapy for cystic fibrosis: Challenges and prospects
Cystic fibrosis (CF) is a life-threatening autosomal-recessive disease caused by mutations in a single gene encoding cystic fibrosis transmembrane conductance regulator (CFTR). CF effects multiple organs, and lung disease is the primary cause of mortality. The median age at death from CF is in the e...
Main Authors: | Hongshu Sui, Xinghua Xu, Yanping Su, Zhaoqing Gong, Minhua Yao, Xiaocui Liu, Ting Zhang, Ziyao Jiang, Tianhao Bai, Junzuo Wang, Jingjun Zhang, Changlong Xu, Mingjiu Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1015926/full |
Similar Items
-
Airway Clearance Therapy in Cystic Fibrosis Patients Insights from a Clinician Providing Cystic Fibrosis Care
by: Chaudary N, et al.
Published: (2021-06-01) -
The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
by: Caitlyn Harvey, et al.
Published: (2022-03-01) -
Review of respiratory physiotherapy methods in patients with cystic fibrosis
by: Oktawia Kuna, et al.
Published: (2023-01-01) -
MicroRNA Expression in Cystic Fibrosis Airway Epithelium
by: Catherine M. Greene
Published: (2013-02-01) -
Defects of secretion in cystic fibrosis /
by: Schultz, Carsten
Published: (2005)